The study team tested whether the NF1 ortholog dNf1 regulates sleep in flies. They found that loss of dNf1 produces a clear, reproducible fragmentation of sleep. Targeted experiments implicated cholinergic neurons as both necessary and sufficient: removing dNf1 from this neuronal class reproduced the mutant phenotype, and restoring wild-type dNf1 in cholinergic neurons of null animals rescued sleep consolidation.
This finding narrows a broad expression pattern to a specific circuit node. Although dNf1 is widely expressed across the adult CNS, the investigators reported that cholinergic neurons—by virtue of being the most abundant class in the fly brain—carry the functional burden for the sleep deficit when dNf1 is absent.
Null dNf1 mutants exhibited reduced total sleep time and blunted nighttime consolidation. The phenotype had multiple measurable components: fewer sleep bouts, shorter bouts, and elevated inter-bout activity during the night. The cohort showed that these features mimic the fragmented, poor-quality sleep reported in patients with Neurofibromatosis 1.
The phenotype behaved recessively. Independent null alleles produced similar sleep deficits, and pan-neuronal RNAi knockdown recapitulated the effect, providing convergent genetic evidence that loss of dNf1 function disrupts normal sleep architecture in the fly.
Investigators surveyed multiple CNS populations. They detected dNf1 expression in mushroom bodies, ellipsoid body, dorsal fan-shaped body, and in GABAergic neurons. Despite that broad expression, cell-type-restricted knockdown in each of those populations did not reproduce the sleep fragmentation, indicating those cells are dispensable for the observed sleep regulation.
In contrast, targeted manipulations of cholinergic neurons were sufficient to both produce and reverse the phenotype. Restoring wild-type dNf1 only in cholinergic neurons of null animals was both necessary and sufficient to normalize sleep metrics reported by the authors, a result that focuses mechanistic attention on this neuronal class.
To probe mechanism, the study team expressed the GAP-related domain (GRD) of dNf1 selectively in cholinergic neurons. The GRD alone, which the authors reported normalizes elevated Ras/MAPK signaling, fully restored sleep in dNf1 nulls. A catalytically dead GRD variant failed to rescue the sleep phenotype.
These observations indicate that dysregulated Ras/MAPK signaling within cholinergic neurons is the proximate cause of sleep fragmentation in this model. The data therefore link a biochemical activity of Neurofibromin—GAP activity toward Ras—to a defined behavioral output: sleep consolidation.
The authors examined two disease-associated missense mutations: dNf1C1045Y and dNf1R1861C. The two variants produced distinct, dose-graded effects on sleep. dNf1C1045Y generated severe deficits resembling the null; it was resistant to pan-neuronal rescue but responded to cholinergic neuron–restricted rescue, consistent with a dominant-negative effect on dimerization as the study team proposed.
By contrast, dNf1R1861C yielded a milder sleep phenotype that was largely reversible by wild-type dNf1 but only partially rescued by the GRD domain. The authors interpreted this difference to mean that R1861C may act through an additional, GRD-independent mechanism.
These mutation-specific results map onto the clinical heterogeneity seen in patients with Neurofibromatosis 1, where sleep disturbance severity varies across genotypes.
The report is a preprint and has not been peer reviewed; readers should interpret results accordingly. The source did not provide detailed electrophysiological recordings or precise behavioral rescue timelines, and it did not report whether downstream molecular targets of Ras/MAPK in cholinergic neurons were identified. The mechanistic basis for the partial, GRD-independent rescue of the R1861C variant remains unresolved in the manuscript. Finally, translation from Drosophila circuits to human sleep regulation requires additional work that the authors did not document in this preprint.
Taken together, the data reported identify cholinergic neurons as the critical circuit for Neurofibromin-dependent sleep consolidation in this Drosophila model and establish Ras/MAPK dysregulation within that neuronal class as the proximal molecular driver of fragmented sleep, while leaving specific downstream effectors and cross-species validation as open questions.